ArticleCancers2024
Synthetic Boosted Resampling Using Deep Generative Adversarial Networks: A Novel Approach to Improve Cancer Prediction from Imbalanced Datasets.
Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Translation readiness of model-based synthetic tabular data in healthcare: a systematic review and governance audit.Journal of the American Medical Informatics Association : JAMIA · 2026Pooled it
- Harnessing Deep Learning Models for Guide RNA Optimization and Off-Target Prediction in CRISPR Systems.Biotechnology journal · 2026Review
- Deep Learning Applications in Clinical Cancer Detection: A Review of Implementation Challenges and Solutions.Mayo Clinic proceedings. Digital health · 2025Review
- Advanced Brain Tumor Classification in MR Images Using Transfer Learning and Pre-Trained Deep CNN Models.Cancers · 2025Article
- Linear B-cell epitope prediction for SARS and COVID-19 vaccine design: Integrating balanced ensemble learning models and resampling strategies.PeerJ. Computer science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesThis study examines the effectiveness of different resampling methods and classifier models for handling imbalanced datasets, with a specific focus on critical healthcare applications such as cancer diagnosis and prognosis.
methodsTo address the class imbalance issue, traditional sampling methods like SMOTE and ADASYN were replaced by Generative Adversarial Networks (GANs), which leverage deep neural network architectures to generate high-quality synthetic data. The study highlights the advantage of GANs in creating realistic, diverse, and homogeneous samples for the minority class, which plays a significant role in mitigating the diagnostic challenges posed by imbalanced data. Four types of classifiers, Boosting, Bagging, Linear, and Non-linear, were assessed to evaluate their performance using metrics such as accuracy, precision, recall, F1 score, and ROC AUC.
resultsBaseline performance without resampling showed significant limitations, underscoring the need for resampling strategies. Using GAN-generated data notably improved the detection of minority instances and overall classification performance. The average ROC AUC value increased from baseline levels of approximately 0.8276 to over 0.9734, underscoring the effectiveness of GAN-based resampling in enhancing model performance and ensuring more balanced detection across classes. With GAN-based resampling, GradientBoosting classifier achieved a ROC AUC of 0.9890, the highest among all models, demonstrating the effectiveness of GAN-generated data in enhancing performance.
conclusionsThe findings underscore that advanced models like Boosting and Bagging, when paired with effective resampling strategies such as GANs, are better suited for handling imbalanced datasets and improving predictive accuracy in healthcare applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.